Endotoxin is not an Essential Mediator in Toxic Shock Syndrome

Reviews of Infectious Diseases

Volumn 11, Issue , 1989, Pages S219-S230

  Melish, Marian E ^a   Murata, Susanna ^a   Fukunaga, Cynthia ^a   Frogner, Kanitha ^a   Hirata, Shirley ^a   Wong, Cecily ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; POLYMYXIN B;

ANIMAL; ARTICLE; DISEASE MODEL; PHYSIOLOGY; RABBIT; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS;

ANIMAL; DISEASE MODELS, ANIMAL; ENDOTOXINS; ENTEROTOXINS; POLYMYXIN B; RABBITS; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024578103     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/11.Supplement_1.S219     Document Type: Article

References (46)

1. Schlievert P. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun 1982;36:123-8
2. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 1981;143:509-16
3. de Azavedo JCS, Arbuthnott JP. Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits. Infect Immun 1984;46:314-7
4. Reeves MW, Arko RJ, Chandler FW, Bridges NB. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits. Infect Immun 1986;51:431-9
5. Stone RL, Schlievert PM. Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis 1987; 155:682-9
6. Nilsson P, Wadstrom T, Vesterberg O. Separation of proteins from carrier ampholytes after isoelectric focusing. Biochem Biophys Acta 1970;221:146-8
7. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol 1957;3:447-54
8. Lowry OH, Resebrough NJ, Far AL, Randal RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75
9. “I-labelled human growth hormone of high specific radioactivity. J Biochem 1963;89:114-2
10. Scott DF, Kling JM, Kirkland JJ, Best GK. Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome using polyethylene infection chambers in rabbits. Infect Immun 1983;39:383-7
11. Arko RJ, Rasheed JK, Broome CV, Chandler FW, Paris AL. A rabbit model of toxic shock syndrome: clinicopatho- logic features. J Infect 1984;8:205-11
12. de Azavedo JCS, Foster TJ, Hartigan PJ, Arbuthnott JP, O’Reilly M, Kreiswirth BN, Novick RP. Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model. Infect Immun 1985;50:304-9
13. Parsonnet J, Gillis ZA, Richter AG, Pier GB. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun 1987;55:1070-6
14. Rasheed JK, Arko RJ, Feeley JC, Chandler FW, Thornsberry C, Gibson RJ, Cohen MJ, Jeffries CD, Broome CV. Acquired ability of Staphylococcus aureus to produce toxic shock associated protein and resulting illness in a rabbit model. Infect Immun 1985;47:598-604
15. Braude AI, Ziegler EJ, Douglas H, McCutchan JA. Antibody to cell wall glycolipid of gram negative bacteria: induction of immunity to bacteremia and endotoxemia. J Infect Dis 1977;136(Suppl):S167-73
16. Luderitz O, Galanos C, Risse HJ, Ruschmann E, Schleet S, Schmidt G, Schulte-Holthansen H, Wheat R, Westphal O. Structured relationships of salmonella O and R antigens Ann NY Acad Sci 1966;133:349-74
17. Osborn MJ. Biosynthesis and structure of the core region of the lipopolysaccharide in Salmonella typhimurium. Ann NY Acad Sci 1966;133:375-83
18. Heath EC, Mayer RM, Edstron RD, Beaudreau CA. Structure and biosynthesis of the cell wall lipopolysaccharide of E. coli. Ann NY Acad Sci 1966;133:315-33
19. Ziegler EJ, Douglas H, Sherman JE, Davis CE, Braude AI. Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase- deficient mutant. J Immunol 1973;111:433-8
20. Ziegler EJ, McCutchan JA, Douglas H, Braude AI. Prevention of lethal pseudomonas bacteremia with epimerase- deficient E. coli antiserum. Trans Assoc Am Physicians 1975;88:101-8.
21. Marks MI, Ziegler EJ, Douglas H, Corbeil LB, Braude AI. Induction of immunity against Hemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest 1982;69:742-9
22. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, Braude AI. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982;307:1225-30
23. Warren HS, Novitsky TJ, Bucklin A, Kania A, Siber GR. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria. Infect Immun 1987;55:1668-73
24. Neter E, Gorzynski EA, Westphal O, Luderitz O. The effects of antibiotics on enterobacterial lipopolysaccharides (endotoxins), hemagglutination and hemolysis. J Immunol 1958;80:66-72
25. Rifkind D, Palmer JD. Neutralization of endotoxin toxicity in chick embryos by antibiotics. J Bacteriol 1966;92:815-9
26. Rifkind D. Prevention by polymyxin B of endotoxin lethality in mice. J Bacteriol 1967;93:1463-4
27. From AHL, Fong JSC, Good RA. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs. Infect Immun 1979; 23:660-4
28. Hughes B, Madan BR, Parratt JR. Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin. Br J Pharmacol 1981;74:701-7
29. Craig WA, Turner JH, Kunin CM. Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues. Infect Immun 1974; 10: 287-92
30. Corrigan J J, Bell BM. Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravas- cular coagulation and leukopenia. Infect Immun 1971; 4:563-6
31. Corrigan JJ, Kiernat JF. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model. Pediatr Res 1979;13:48-51
32. Walterspiel JW, Kaplan SL, Mason EO. Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection and the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment. Pediatr Res 1986;20:237-41
33. Lopes J, Inniss WE. Electron microscopy of the effect of polymyxin on Escherichia coli lipopolysaccharide. J Bacteriol 1969;100:1128-30
34. Flynn PM, Shenep JL, Stokes DC, Fairclough D, Hildner WK. Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia. J Infect Dis 1987;156:706-12
35. Braude A. Opposing effects of immunity to endotoxin: hypersensitivity versus protection. In: Urbaschek B, Urbaschek R, Neter E, eds. Gram-negative bacterial infections. New York: Springer-Verlag, 1975:69
36. Beeson P. Effect of reticuloendothelial blockade in immunity to the Shwartzman phenomenon. Proc Soc Exp Biol Med 1947;64:146
37. Fujikawa H, Igarashi H, Usami H, Tanaka S, Tamura H. Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1. Infect Immun 1986;52:134-7
38. Chow AW, Bartlett KH, Percival-Smith R, Morrison BJ. Vaginal colonization with Staphylococcus aureus, positive for toxic shock marker protein, and Escherichia coli in healthy women. J Infect Dis 1984;150:80-4
39. Chu MC, Melish ME, James JF. Growth of TSST-l-producing, tryptophan-requiring Staphylococcus aureus is associated with the presence of Escherichia coli. Rev Infect Dis 1989;11(Suppl 1):S101—3
40. Ikejima T, Dinarello CA, Gill DM, Wolff SM. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest 1984; 73:1312-20
41. Parsonnet J, Hickman RK, Eardley DD, Pier GB. Induction of human interleukin 1 by toxic shock syndrome toxin 1. J Infect Dis 1985;151:514-22
42. Parsonnet J, Gillis ZA. Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin 1. J Infect Dis 1988;158:1026-33
43. Ikejima T, Okusawa S, Van Der Meer JWM, Dinarello CA. Toxic shock is mediated by IL-1 and TNF [abstract]. In:Program and abstracts of International Symposium on Toxic Shock Syndrome. Atlanta, Ga, 15-18 November 1987
44. Drumm A, de Azavedo JCS, Arbuthnott JP. Damaging effect of toxic shock syndrome toxin 1 on chick embryo cells in vitro. Rev Infect Dis 1989;ll(Suppl 1):S375-81
45. Kushnaryov VM, Bergdoll MS, MacDonald HS, Vellinga J, Reiser R. Study of staphylococcal toxic shock syndrome toxin in human epithelial cell culture. J Infect Dis 1984; 150:535-45
46. Kushnaryov VM, MacDonald HS, Bergdoll MS. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev Infect Dis 1989;ll(Suppl I): S282-8